[Other] Nintedanib in systemic sclerosis-associated interstitial lung disease: real-world cohort study on tolerability and discontinuation

thuycan Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-07-08 10:52
Reward20points

journal:Clinical and Experimental Rheumatology

Authors:Punchalee Kaenmuang; Nina R. Goldman; Arthihai Srirangan; Fiammetta Danzo; Wing-Ho Yip; Ali Taki; Shereen Boreland; Benedetta Vitri; Carmel J.W. Stock; Christopher P. Denton; Athol U. Wells; Voon H. Ong; Piersante Sestini; Elisabetta A. Renzoni

Published date:--

DOI:10.55563/clinexprheumatol/dvur8b

Article link:https://doi.org/10.55563/clinexprheumatol/dvur8b

Article Source:Clinical and Experimental Rheumatology


Remark:
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list